Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 301 | $9.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 302 | $9.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 303 | $9.50M | Healthcare | Pharmaceuticals | United States | NYSE |
| 304 | $9.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 305 | $9.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 306 | $8.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 307 | $8.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 308 | $8.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 309 | $8.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 310 | $8.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 311 | $8.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 312 | $8.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 313 | $7.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 314 | $7.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 315 | $7.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 316 | $6.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 317 | $6.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 318 | $6.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 319 | $5.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 320 | $5.91M | Healthcare | Pharmaceuticals | United States | NYSE |
| 321 | $5.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 322 | $5.49M | Healthcare | Pharmaceuticals | United States | NYSE |
| 323 | $5.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 324 | $5.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 325 | $5.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 326 | $5.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 327 | $5.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 328 | $4.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 329 | $4.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 330 | $4.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 331 | $4.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 332 | $4.46M | Healthcare | Pharmaceuticals | United States | NYSE |
| 333 | $4.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 334 | $3.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 335 | $3.41M | Healthcare | Pharmaceuticals | United States | NYSE |
| 336 | $3.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 337 | $3.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 338 | $2.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 339 | $2.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 340 | $1.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 341 | $1.41M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 342 | $0.00M | Healthcare | Pharmaceuticals | — | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 342 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.